top of page

2024 NLA Scientific Sessions Abstracts

Click on the posters to see an enlarged version, or scan the QR Codes with your phone to have a touch-free experience. 

Atrial Fibrillation Outcome in Patients with Metabolic Syndrome.

Presenting Author: Joseph Amoah, MD
Authors: Brittany Smith, Michael Fatuyi, Francisco Somaza Cano


Poster 222


Kiosk 28

Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Deep and Durable TG Reductions in Patients With SHTG, SHASTA-2 Final Results

Presenting Author: Christie Ballantyne, MD
Authors: Gaudet D, Pall D, Watts GF, Nicholls SJ, Rosenson RS, Modesto K, Chang T, Melquist S, Fu R, Muhsin M, San Martin J

Poster 131


Kiosk 28

Study Design of a Phase 3 Randomized Controlled Trial Evaluating the Efficacy and Safety of Pegozafermin in Patients with Severe Hypertriglyceridemia

Presenting Author: Teresa Parli, MD
Authors: Deepak L. Bhatt MD MPH, Maciej Banach MD, Harold E. Bays, MD, Kevin C. Maki PhD, Kausik Ray MD, Guilliermo Umpierrez MD, Cynthia L. Hartsfield PhD, Germaine D. Agollah PhD, Hank Mansbach MD, Teresa Parli MD, John J. P. Kastelein MD PhD, Arun J. Sanyal MD.


Poster 153


Kiosk 28

Treatment Patterns Among Early Inclisiran vs Anti–PCSK9 mAbs Users: A Retrospective Analysis of US Claims Databases

Presenting Author: Xiaoli Niu, PhD
Authors: Lyuba Popadic, Xinshuo Ma, Yousfuf Ali, Pam Kumparatana, Yuqin Wei, Sean McElligott


Poster 158


Kiosk 28

bottom of page